Related Experiment Video
Updated: Jul 4, 2026

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography
Published on: August 25, 2023
ABCG2 transporter: Structural and functional associations with gout (Review)
Muhammad Arslan Asif1, Zeshan Zulfiqar1, Bahar E Mustafa2
1Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, Henan Agricultural University, Zhengzhou, Henan 450000, P.R. China.
Dysfunctional ATP-binding cassette sub-family G member 2 (ABCG2) impairs urate excretion, increasing gout risk. The Q141K variant reduces urate transport, impacting treatment response and necessitating novel therapeutic strategies.
Area of Science:
- Biochemistry and Molecular Biology
- Genetics and Genomics
- Physiology and Pathophysiology
Background:
- ATP-binding cassette sub-family G member 2 (ABCG2) is crucial for urate homeostasis.
- ABCG2 dysfunction is a significant genetic risk factor for hyperuricemia and gout.
- ABCG2 acts as a high-capacity urate efflux pump in key organs.
Purpose of the Study:
- To review the molecular structure, physiological functions, and pathophysiological effects of ABCG2.
- To focus on the common Q141K loss-of-function variant and its impact on urate transport and disease risk.
- To explore ABCG2's role in the urate transportome and its novel regulatory mechanisms.
Main Methods:
- Literature review of ABCG2's structure, function, and genetics.
- Analysis of the Q141K variant's impact on protein stability, trafficking, and urate transport.
- Exploration of ABCG2 interactions with other transporters and regulatory factors like the gut microbiome.
Main Results:
- The Q141K variant impairs ABCG2 stability and urate transport, elevating gout and cardiorenal comorbidity risk.
- ABCG2 interacts dynamically with other urate transporters and is regulated by gut microbial metabolites.
- Q141K carriers show diminished efficacy with uricosuric drugs, highlighting pharmacogenomic implications.
Conclusions:
- Understanding ABCG2's multifaceted role is key to addressing impaired urate excretion.
- Emerging therapies like ABCG2 activators and microbiome modulators offer personalized gout prevention and treatment.
- Targeted strategies focusing on ABCG2 are essential for managing hyperuricemia and gout.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
ABC Transporters: Exporter
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
